AstraZeneca reported good news on a vaccine candidate, Goldman Sachs upgraded its price target for Amazon, and an oil giant announced a strategic acquisition at what looks like a reasonable price. Read More...
AstraZeneca reported good news on a vaccine candidate, Goldman Sachs upgraded its price target for Amazon, and an oil giant announced a strategic acquisition at what looks like a reasonable price.
Add Comment